Related Experiment Video

Updated: Dec 22, 2025

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt
12:27

Technique of Porcine Liver Procurement and Orthotopic Transplantation using an Active Porto-Caval Shunt

Published on: May 7, 2015

16.8K

Vitamin D-Binding Protein (Gc-Globulin) in Acute Liver Failure in Children

Alina Grama1,2,3, Lucia Burac1,2, Cornel Olimpiu Aldea4

  • 12nd Paediatric Clinic, University of Medicine and Pharmacy "Iuliu Hatieganu", 400177 Cluj-Napoca, Romania.

Diagnostics (Basel, Switzerland)
|May 8, 2020
PubMed

Insights

Vitamin D-binding protein (Gc-globulin) serum levels are significantly lower in children with acute liver failure (ALF). Lower Gc-globulin levels indicate poor disease outcomes and correlate with ALF severity markers.

Area of Science:

  • Pediatric Hepatology
  • Clinical Biochemistry
  • Biomarker Discovery

Background:

  • Acute liver failure (ALF) in children is a critical condition with high mortality.
  • Identifying reliable biomarkers for ALF severity and prognosis is crucial for timely intervention.
  • Vitamin D-binding protein (Gc-globulin) is involved in various biological processes, but its role in pediatric ALF is not well-established.

Purpose of the Study:

  • To analyze serum vitamin D-binding protein (Gc-globulin) levels in children with ALF.
  • To evaluate the correlation of Gc-globulin levels with ALF disease outcomes.
  • To assess the relationship between Gc-globulin levels and other established ALF severity markers.

Main Methods:

  • A cohort study involving 34 children diagnosed with ALF and 30 healthy controls.
  • Serum Gc-globulin levels were measured using standard laboratory techniques.
  • Statistical analysis was performed to compare Gc-globulin levels between groups and correlate them with clinical outcomes and severity scores.

Main Results:

  • Serum Gc-globulin levels were significantly lower in children with ALF compared to controls (151.57 vs. 498.63 mg/L, p < 0.000001).
  • Lower Gc-globulin levels were observed in ALF patients with poor outcomes (59.34 mg/L) compared to survivors (216.12 mg/L, p < 0.0001).
  • Gc-globulin levels showed significant correlations with established ALF severity markers and varied based on ALF etiology.

Conclusions:

  • Serum Gc-globulin is a potential biomarker for identifying children with ALF.
  • Decreased Gc-globulin levels are associated with poor prognosis in pediatric ALF.
  • Gc-globulin measurement may aid in risk stratification and management of children with acute liver failure.

Keywords:
Gc-globulinacute liver failurechildrenliver transplantmortalityprognostic markervitamin D binding protein

More Related Videos

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen09:44

Generation of a Rat Model of Acute Liver Failure by Combining 70% Partial Hepatectomy and Acetaminophen

Published on: November 27, 2019

10.8K
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target11:34

A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target

Published on: May 10, 2022

2.6K

Related Concept Videos

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
120
Drug Distribution: Plasma Protein Binding01:29

Drug Distribution: Plasma Protein Binding

Drugs predominantly attach to plasma proteins, with only a small percentage remaining unbound. The unbound portion can be calculated as one minus the bound fraction. Acidic drugs form large, inactive complexes by reversibly binding to plasma albumin, which prevents them from diffusing across biological barriers. These drug-protein complexes act as reservoirs for the drugs. As the concentration of unbound drugs decreases, these complexes quickly dissociate to release the free drug, maintaining...
8.1K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
243
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
156
Hepatic Drug Clearance: Effect of Protein Binding01:09

Hepatic Drug Clearance: Effect of Protein Binding

Hepatic clearance is influenced by protein binding based on the drug's extraction ratio. Drugs with high extraction ratios are considered flow-limited and remain unaffected by protein binding during hepatic clearance. On the other hand, drugs with low extraction ratios may be impacted by plasma protein binding, although the extent of this influence depends on the fraction of the drug bound.
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
461
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
194